baber/WOPTO huggingface dataset:
Patent AT-E362983-T1 (AT)
Inventor: FUKUSHIMA DAIKICHI
IPC: A61K38/00
Filed: 1998-11-10
Granted: 2007-06-15
Abstract: (1) A human lysophosphatidic acid (human LPA) receptor, (2) a method for screening an antagonist or agonist, comprising using a human LPA receptor protein, (3) an LPA inhibitor comprising the human LPA receptor, (4) a method for producing the human LPA receptor, (5) a monoclonal or polyclonal antibody against the human LPA receptor, (6) a cDNA encoding the human LPA receptor, (7) a replication or expression vector carrying the above cDNA, and (8) a host cell transformed with the above replication or expression vector.
Patent AT-E263794-T1 (AT)
Inventor: REVELANT DENIS
IPC: C08G18/02
Filed: 1998-11-04
Granted: 2004-04-15
Abstract: This invention relates to a process for separating one (or more) oligomeric or polymeric compound(s) (A) obtained by polymerization of isocyanate monomers (A1) or copolymerization of isocyanate monomers with another polymerizable compound (A2), in particular a polyol, the said compound(s) A having a viscosity (a), from the unconverted monomer(s), this process comprising addition to the said compound(s) (A) of one (or more) compound(s) (B) consisting of the product of polymerization of isocyanate monomers (B1) or of copolymerization of isocyanate monomers with another polymerizable compound (B2), in particular a polyol, the said compound(s) (B) having a viscosity (b) and the ratio of the viscosities b/a being less than 1/1.5, preferably less than 1/2, and co-distillation of (A) and (B), in order to separate the compound(s) (A) from the corresponding unconverted monomers.
Patent AT-E250443-T1 (AT)
Inventor: KAWASHIMA MASATAKE
IPC: A62D3/176
Filed: 1999-02-06
Granted: 2003-10-15
Abstract: Disclosed herein are a solid waste treatment agent comprising phosphorous acid or a derivative thereof and/or hypophosphorous acid or a derivative thereof, or phosphorous acid or a derivative thereof and/or hypophosphorous acid or a derivative thereof, and an aluminum compound and/or a titanium compound, and a method of treating solid waste, which comprises adding the solid waste treatment agent to solid waste containing harmful metals and/or organic chlorinated compounds such as dioxins and PCB to make the solid waste harmless. When the solid waste treatment agent comprising phosphorous acid or a derivative thereof and/or hypophosphorous acid or a derivative thereof, and titanium oxide, or comprising phosphorous acid or a derivative thereof and/or hypophosphorous acid or a derivative thereof, titanium oxide and an aluminum compound is used as a solid waste treatment agent to treat solid waste under irradiation of rays, the solid waste can be effectively made harmless even when the treatment is conducted at a relatively low temperature.
Patent AT-E222855-T1 (AT)
Inventor: FRANZ KARL-HEINZ
IPC: B41F31/14
Filed: 1999-04-23
Granted: 2002-09-15
Abstract: The method comprises color rollers (81,82) between which is fed the pigment via a switching roller (8). A control unit (9) is provided which sets the position of the switching roller depending on the state of the machine and the paper.
Patent AT-E336019-T1 (AT)
Inventor: KLEES ERNST
IPC: G02B6/38
Filed: 1999-11-09
Granted: 2006-09-15
Abstract: The connection box (2) has at least one plug connector for the connecting cable (7) and at least one (4) for the line cable mounted on the connection box and connected together within the connection box by a connecting optical fibre waveguide (8). The connection box is in the form of an essentially closed box.
Patent AT-E322085-T1 (AT)
Inventor: GARVISON PAUL
IPC: E04D3/40
Filed: 1999-07-14
Granted: 2006-04-15
Abstract: A multi-purpose photovoltaic module framing system is provided which combines and integrates the framing system with the photovoltaic electrical system. The user friendly framing system is easy to install and can be directly mounted to a roof surface without auxiliary brackets and beams. The economical framing system has aesthetically pleasing frames to mechanically hold and support photovoltaic modules. The multi-purpose frames desirably have integral electrical raceways which conceal and protect most electrical components and wires. The reliable frames are specially constructed and arranged to permit easy access to output wires and do not require junction boxes. Ground clips can be directly connected to the convenient framing system. <IMAGE>
Patent AT-E543093-T1 (AT)
Inventor: ADAMS MATTHEW
IPC: G06T1/00
Filed: 1999-09-09
Granted: 2012-02-15
Abstract: An apparatus (1) for acquiring high resolution digital images from a large area specimen, such as the result of an electrophoresis of a fluorescent labeled sample in a gel (3). The apparatus comprises a variable wavelength light source (4), variable across a continuous range of wavelengths, for providing illuminating light to the specimens. Image obtaining means (5) are provided for obtaining a high resolution image of the illuminating specimen together with image analysing means for analysing the obtained image to determine the location of samples on the specimen and to provide data based thereon. <IMAGE>
Patent AT-E249455-T1 (AT)
Inventor: NISHI TAKAHIDE
IPC: A61P11/06
Filed: 1999-01-22
Granted: 2003-09-15
Abstract: To provide compounds exhibiting antagonism to each of NK1, NK2 and NK3 receptors. ÄMeans for SolutionÜ   A compound represented by the formula (I): <CHEM> (wherein R<1>, R<2>: a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group; A: CH2, CO or SO2; B: single bond, alkylene or alkenylene, D: O or S; E: alkylene or alkenylene; <CHEM> Äwherein G: a substituted or unsubstituted cycloalkene ring, or a substituted cycloalkane ring; Ar: a substituted or unsubstituted aryl ring, or a substituted or unsubstituted heteroaryl ringÜ; R<3>: alkyl; n: 1-3ü, or a pharmacologically acceptable salt, ester or other derivative thereof
Patent AT-E479753-T1 (AT)
Inventor: NAGATA MASAMI
IPC: A61K38/00
Filed: 1999-02-02
Granted: 2010-09-15
Abstract: This invention provides the TSC403 gene having a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1, which is a novel gene of great utility particularly in the field of research, diagnosis, therapy, etc. for cancer of the lung, among other diseases.  In addition, this invention provides the human ING1L gene comprising a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:4, which is a novel human gene useful for regulating the cell cycle, inhibiting or activating cell proliferation, studies on metabolic aging or apoptosis of cells, pathological exploration, diagnosis and therapy of cancer and other diseases, and screening for the development of new drugs.
Patent AT-E244908-T1 (AT)
Inventor: MOELLER GERT LYKKE SOERENSEN
IPC: G06F17/30
Filed: 1999-03-16
Granted: 2003-07-15
Abstract: A method and apparatus provide the ability to generate and use a database representing all solutions (legal combinations) satisfying all constraints of configuration problems on finite domains and/or intervals. The configuration space with all legal combinations is stored in a compact way in terms of nested arrays, where each legal Cartesian subspace has a unique index. Thus, the complete configuration space (which can be extended with object functions for optimization) is easily addressable by parallel indexing techniques and the database is therefore suitable for run-time applications (e.g. configuration on the Internet), which must be performed in real time.</PTEXT>
Patent AT-E316402-T1 (AT)
Inventor: GREFF RICHARD J
IPC: A61B17/12
Filed: 1999-02-26
Granted: 2006-02-15
Abstract: This invention is directed to novel methods for gynecologic embolotherapy. The methods directly access the blood vessels to be embolized transcervically rather than arterially. The methods provide precise directed delivery of embolizing compositions, and are particularly suited for treating uterine fibroids. Kits containing one or more devices for transcervical injection and an embolizing composition are also provided. In a preferred embodiment, fluid embolizing compositions are used. In a more preferred embodiment, these fluid embolic compositions comprise a biocompatible polymer, a biocompatible solvent and a biocompatible water insoluble constrast agent. In a most preferred embodiment, the contrast agent is characterized by having an average particle size of about 10 µm or less.
Patent AT-E525477-T1 (AT)
Inventor: MURPHY GERALD
IPC: G01N33/53
Filed: 1999-03-29
Granted: 2011-10-15
Abstract: The present invention relates to the identification of a novel role of CXCR-4 in cell transformation and aberrant cellular proliferation. In particular, the present invention relates to the altered gene expression of CXCR-4 in a number of primary tumors and cell lines derived from tumors, in addition to, the altered gene expression of ligands for CXCR-4. Further, the present invention relates, in part, to the Applicants' surprising discovery that the inhibition of CXC R- 4 gene expression or the inhibition of CXCR-4 activity in transformed cells reverses the transformed phenotype.
Patent AT-E298060-T1 (AT)
Inventor: PRESSI ANGELO
IPC: F16L11/08
Filed: 1999-04-28
Granted: 2005-07-15
Abstract: The invention relates to a coupling pipe for water heating and/or conditioning systems, of the type having one or more braided layets (2, 3). The main feature of the invention is that the pipe comprises, in the inside of the braided coating thereof, a first and a second tubular layer (4, 5), the first tubular layer being made of a halogenated thermopolymeric material (EPDM), and the second layer being made of a halogen-butylelastomeric material. The present invention also relates to a method for making the pipe.
Patent AT-E305922-T1 (AT)
Inventor: CARENCOTTE FREDERIC
IPC: C07C323/52
Filed: 1999-07-07
Granted: 2005-10-15
Abstract: The invention concerns an improved method for separating hydroxymethylthiobutyric acid by neutralising hydroxymethylthiobutyronitrile sulphuric hydrolysate, decanting and treating each phase with an organic solvent.
Patent AT-E222661-T1 (AT)
Inventor: KRESS JUERGEN
IPC: G06T1/00
Filed: 1999-05-26
Granted: 2002-09-15
Abstract: The invention relates to a method for reducing noise and artefacts in digital subtraction imaging processes. A subtraction image data set is produced from two volume data sets, each volume data set consisting of a number of elements (voxels). A uni- or multidimensional vector (grey-scale value) is allocated to each voxel. A first m-dimensional limit vector, m corresponding to the number of dimensions of the vectors of the subtraction image data set, and a first proximity relation between the voxels of the subtraction image data set are defined. At least the n-te (n  ELEMENT  N>+<) component of the m components of all of the vectors of the subtraction data set in each case is compared with the nth component of the first limit vector and when a predetermined first selection condition is fulfilled, are set at a predetermined first unit value. Each nth component of a voxel-allocated vector which does not fulfil the first selection condition is compared with the nth components of the vectors allocated to the voxels deemed closest to the voxel concerned according to the first proximity relation and when a predetermined second selection condition is fulfilled, is also set at the predetermined first unit value.
Patent AT-E260511-T1 (AT)
Inventor: BAUER ROLF DIETER
IPC: H01H73/02
Filed: 1999-08-02
Granted: 2004-03-15
Abstract: The invention relates to a switch-operating lever unit for switches, comprising a switch-operating lever body (2) on which a contact lever (3) is mounted. Caps (8) for covering and mounting the switch-operating lever body (2) are arranged at two opposite ends of said body (2). The unit can further comprise a tensioning device which can act on the contact lever and is positioned either outside the space housing the contact lever and within the switch-operating lever body or is covered and mounted on the switch-operating lever body (2).
Patent AT-E226777-T1 (AT)
Inventor: KEESEN HEINZ-WERNER
IPC: H04N5/92
Filed: 1999-08-26
Granted: 2002-11-15
Abstract: A settop box can be connected to a DVD Streamer via an IEEE1394 interface which contains means to timestamp data and to strip off these timestamps again, using them for timing regeneration. The DVD Streamer also must re-generate the timing of data packets as it was upon recording, when these packets are placed back. The streamer could also use own timestamps and strip them off again when replaying. So, in total, there is an in-series connection between two time stamping and time regeneration mechanisms which introduces jitter accumulation. The settop box itself adds time stamps to the data packets before sending them through the IEEE1394 interface. These timestamps pass the IEEE1394 interface unnoticed, i.e. as part of the payload. These timestamps are used when the DVD Streamer plays back a stream. The advantage is that there is only one timing/regeneration process involved and that no jitter is accumulated. As an alternative, the stream recorder uses the IEEE1394 timestamps and evaluates them when replaying in order to assign to the data packets the correct temporal position. <IMAGE>
Patent AT-E235083-T1 (AT)
Inventor: DRUMMOND BRIAN L
IPC: G06F15/78
Filed: 1999-09-23
Granted: 2003-04-15
Abstract: A system and method for providing a sustained, peak performance computing architecture is provided. A hardware processing architecture is provided for performing repeated algorithm iterations, wherein each of the algorithm iterations is performed on a parallel set of algorithm input data. The architecture includes a memory arranged to store the algorithm input data in parallel, contiguous bit locations. A parallel execution module having a plurality of functional execution units is provided, each of the functional execution units being configured to perform a preassigned function dictated by the algorithm on predetermined bits of each iterative parallel set of algorithm input data. A data flow module is coupled to the memory and to the parallel execution module, and is configured to replicate in hardware the control constructs and expression evaluations of the algorithm, and to distribute the input data to the plurality of function execution units in accordance with the control constructs and expression evaluations of the algorithm.
Patent AT-E314485-T1 (AT)
Inventor: RYLL THOMAS
IPC: C07K14/715
Filed: 1999-05-26
Granted: 2006-01-15
Abstract: The present invention relates to novel process for the preparation of glycoproteins by mammalian cell culture wherein the sialic acid content of the glycoprotein recovered is optimized by manipulating the cell culture environment. The invention provides for processes in which the sialic acid content of the glycoprotein recovered is increased by addition of copper ion to a cell culture at a concentration effective for stabilization of the sialic acid content.
Patent AT-E343401-T1 (AT)
Inventor: ZALUTSKY MICHAEL R
IPC: A61K49/00
Filed: 1999-11-30
Granted: 2006-11-15
Abstract: Antibodies to cell surface ligands such as EGFRvIII can be used to therapeutically or diagnostically deliver a radiolabel to tumor cells with high selectivity. The utility of radioconjugated internalizing antibodies is limited, however, by release of the label and its reuptake into normal cells. The invention provides new technology for radioconjugation of internalizing antibodies which reduces the release of label and improves retention of radioconjugated antibodies in lysosomes, where radiation is more effectively and selectively delivered to the nucleus of tumor cells.
Patent AT-E255342-T1 (AT)
Inventor: PATTERSON GREGORY S
IPC: A45F5/02
Filed: 1999-12-29
Granted: 2003-12-15
Abstract: A clip is provided for releasably securing an article of personal use, the article having a stud with a head spaced from the article. The clip includes a base connectable to a strap and a spring member biased against the base. The base includes a recess hole adapted to receive the stud head. The spring member includes a slot therein extending to an end substantially aligned with the recess hole, with the aligned end of the slot having a first width less than a diameter of the stud head.
Patent AT-E416479-T1 (AT)
Inventor: STOISIEK MICHAEL
IPC: H01L29/749
Filed: 1999-12-08
Granted: 2008-12-15
Abstract: Component having a blocking pn junction having an edge termination structure which is formed by a further, more weakly doped region (5) and a trench (8) formed therein, said trench being filled with a dielectric. The dielectric material in the trench (8) diverts the equipotential areas from the horizontal in a very confined space in the vertical direction, with the result that the electric field can emerge from the component within a small region of the chip surface.
Patent AT-E347228-T1 (AT)
Inventor: TAKEDA TAKESHI
IPC: H04R1/00
Filed: 1999-12-27
Granted: 2006-12-15
Abstract: The object is to provide an ultra-compact mobile communication unit which is smaller in size and lighter in weight. Furthermore, this ultra-compact mobile communication unit enables a user thereof to easily perceive any sounds in communication even in a high-noise environment, and also enables the user to speak in a whisper without making the people around the user uncomfortable. The ultra-compact mobile communication unit is characterized by its bone conduction speaker 1. This bone conduction speaker 1 is separated from the mobile communication unit's main body 2, and used in place of the mobile communication unit's main body's speaker and an external earphone connected with the mobile communication unit. <IMAGE>
Patent ES-2215498-T1 (ES)
Title: Procedimiento para producir fundicion liquida en un horno electrico.
Inventor: ROTH JEAN-LUC
IPC: C21B11/10
Filed: 2002-02-20
Abstract: Procedimiento para producir fundición líquida en un horno de arco eléctrico que comprende varios electrodos, equipado con una solera y que contiene un fondo de baño coronado por una escoria líquida no espumosa, comprendiendo el procedimiento las etapas siguientes: a) reducción de finos metálicos para formar unos finos metálicos prerreducidos que comprenden un exceso de carbono libre, b) traslado en caliente de los finos metálicos prerreducidos al interior de una cortina de un gas inerte en un fondo de baño contenido en el horno de arco eléctrico, c) agitación del fondo de baño mediante inyección de gas de manera que se evite la formación de costras, y d) fusión de los finos metálicos prerreducidos en el horno de arco eléctrico para obtener fundición líquida.
Patent ES-2146566-T1 (ES)
Title: Aparato transportador.
Inventor: TAKAHASHI KAZUHIRO
IPC: B65G47/26
Filed: 1999-10-05
Abstract: Un aparato de transporte para transportar elementos transportables a lo largo de la dirección de transporte sin deslizamiento posicional incluye una línea de transporte (2), una cantidad de pines de guía (3) que se mueven en la dirección del transporte a lo largo de la línea de transporte (2) y que son capaces de un movimiento recíproco en la dirección ortogonal a la dirección de transporte, y un mecanismo para mover los predichos pines de guía (3) seleccionados de la multitud de pines de guía en la dirección ortogonal, en donde los pines de guía (3) se pueden mover recíprocamente entre la posición de funcionamiento elevándose sobre la línea de transporte para que las puntas de los pines de guía (3) puedan entrar en contacto con los objetos transportables (1), y una posición base que no está elevada sobre la línea de transporte.
Patent CY-1107051-T1 (CY)
Inventor: JONES TERENCE R
IPC: A61K38/00
Filed: 2007-01-16
Abstract: A peptide compound having the sequence Lys-Pro-Ser-Ser-Pro-Pro-Glu-Glu [SEQ ID NO:2] or a substitution variant, addition variant or other chemical derivative thereof inhibits cell invasion, endothelial tube formation or angiogenesis in vitro. A number of substitution variants and addition variants of this peptide, preferably capped at the N- and C-termini, as well as peptidomimetic derivates, are useful for treating diseases and conditions mediated by undesired and uncontrolled cell invasion and/or angiogenesis. Pharmaceutical compositions comprising the above peptides and derivatives are administered to subjects in need of such treatment in a dosage sufficient to inhibit invasion and/or angiogenesis. The disclosed compositions and methods are particularly useful for suppressing the growth and metastasis of tumors.
Patent CY-1109461-T1 (CY)
Title: Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
Inventor: ROBERTSON JOHN FORSYTH RUSSELL
IPC: G01N33/53
Filed: 2009-10-05
Abstract: Η εφεύρεση αναφέρεται σε μια μέθοδο ανίχνευσης μιας ασθένειας ή της προδιάθεσης για μια ασθένεια σε ένα θηλαστικό η οποία περιλαμβάνει την ανίχνευση ενός αντισώματος σε ένα δοκιμαστικό δείγμα που περιλαμβάνει ένα σωματικό υγρό από το αναφερόμενο θηλαστικό όπου το αναφερόμενο αντίσωμα είναι ένας βιολογικός δείκτης της κατάστασης μιας νόσου ή προδιάθεσης για μια νόσο, με την μέθοδο να περιλαμβάνει: (α) την επαφή του αναφερόμενου δοκιμαστικού δείγματος με μια πληθώρα διαφορετικών ποσοτήτων ενός αντιγόνου ειδικού για το αναφερόμενο αντίσωμα, (β) την ανίχνευση της ποσότητας της ειδικής πρόσδεσης μεταξύ του αναφερόμενου αντισώματος και το αναφερόμενου αντιγόνου, (γ) τον σχεδιασμό ή τον υπολογισμό μιας καμπύλης της ποσότητας της αναφερθείσας πρόσδεσης έναντι της ποσότητας του αντιγόνου- για την κάθε ποσότητα αντιγόνου που χρησιμοποιήθηκε στα στάδια (α) και (δ) τον καθορισμό της παρουσίας ή απουσίας της αναφερόμενης ασθένειας ή της προδιάθεσης για μια ασθένεια βάσει της ποσότητας της ειδικής πρόσδεσης μεταξύ του αναφερόμενου αντισώματος και του αναφερόμενου αντιγόνου σε κάθε διαφορετική συγκέντρωση του αντιγόνου που χρησιμοποιήθηκε.
Patent CY-1109526-T1 (CY)
Inventor: FRASCH EUGEN
IPC: A61M5/28
Filed: 2009-10-26
Abstract: Identifying and/or testing and/or releasing, in particular, prefilled medical syringes before their application especially by the patient, comprising using a test device incorporating a reader (2) for a code on the syringe introduced axially and/or rotated in the test device, is new. A signal depending on the result of a comparison between the read and stored data is issued by the test device. An independent claim is also included for a test device for implementation of the proposed method.
Patent CY-1112361-T1 (CY)
Title: Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
Inventor: TAKAHASHI NAOTO
IPC: A61K33/243
Filed: 2011-04-18
Abstract: Η ΕΤ-743 χρησιμοποιείται στην παρασκευή φαρμακευτικού σκευάσματος για αποτελεσματική θεραπεία όγκου, με συνδυαστική θεραπεία στην οποία χρησιμοποιείται η ΕΤ-743 με άλλο φάρμακο.
Patent CY-1113124-T1 (CY)
Inventor: LICHTENSTEIN ANATOLY V
IPC: C12Q1/68
Filed: 2012-08-08
Abstract: A method of analysing a target nucleic acid sequence in a urine sample, said method comprising assaying said urine sample for the presence of said target nucleic acid sequence that has crossed the kidney barrier. The present invention provides a method for detecting a non-host nucleic acid sequence in a patient, said method comprising assaying a urine sample, obtained from an individual, for a nucleic acid sequence that: 
(i) is from outside the urinary tract, 
(ii) has crossed the kidney barrier, and 
(iii) does not originate from the patient's endogenous nucleic acid sequences, wherein contaminating nucleic acids in the urine sample comprising greater than 1000 base pairs, or 1000 nucleotides when denatured are removed from the sample prior to detection of said non-host nucleic acid.
Patent CY-1113843-T1 (CY)
Title: Πολυμορφα ενος αναστολεα c-met/hgfr
Inventor: CUI JINGRONG JEAN
IPC: A61P35/00
Filed: 2013-03-22
Abstract: Αυτή η εφεύρεση αναφέρεται σε πολύμορφα της (R)-3-[1-(2,6-διχλωρο-3-φθορο-φαινυλ)-αιθοξυ]-5-(1-πιπεριδιν-4-υλ-1Η-πυραζολ-4-υλ)-πυριδιν-2-υλαμίνης τα οποία είναι χρήσιμα στη θεραπεία της ανώμαλης κυτταρικής ανάπτυξης, όπως του καρκίνου, σε θηλαστικά. Αυτή η εφεύρεση αναφέρεται επίσης σε συνθέσεις οι οποίες περιέχουν τέτοια άλατα και πολύμορφα, και σε μεθόδους χρήσης τέτοιων συνθέσεων στη θεραπεία της ανώμαλης κυτταρικής ανάπτυξης σε θηλαστικά, ειδικά σε ανθρώπους.